ORIGINAL RESEARCH article
Front. Neurosci.
Sec. Neuroendocrine Science
Volume 19 - 2025 | doi: 10.3389/fnins.2025.1608017
This article is part of the Research TopicNeuroendocrine control of glucose homeostasis in health and diseaseView all articles
Adrenergic Signals Influence Proteomic Responses in Breast Cancer Cells
Provisionally accepted- 1Centre for Cancer Biomarkers, Faculty of Medicine, University of Bergen, Bergen, Hordaland, Norway
- 2Department of Pathology, Haukeland University Hospital, Bergen, Hordaland, Norway
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Breast cancer remains a major health challenge due to its molecular heterogeneity and complex interactions with the tumor microenvironment. Adrenergic signaling, mediated by stress hormones such as noradrenaline, has emerged as a potential regulator of cancer progression, influencing cell proliferation, cell adhesion, migration, and invasion. This study investigates the effects of adrenergic modulation on breast cancer spheroids from basal-like (MDA-MB-231, BT549) and luminal-like (T47D, MCF7) cell lines, using 3D culture systems as a more physiologically relevant model compared to traditional 2D monolayer cultures. The 3D spheroid model better recapitulates the structural complexity of tumors, providing insights into cell-cell and cell-matrix interactions that influence signaling pathways and drug responses. Noradrenaline treatment significantly reduced spheroid size, invasion capacity, and the expression of EMT-related markers and integrins in MDA-MB-231 cells. These effects were partially reversed by propranolol, a non-selective beta-adrenergic receptor antagonist. Luminal-like spheroids, characterized by low ADRB2 abundance, displayed limited responsiveness to adrenergic modulation. Proteomic analysis revealed distinct subtype-specific responses, with basal-like spheroids showing pronounced alterations in pathways related to proliferation, cytoskeletal dynamics, epithelial-mesenchymal transition, and metabolism, whereas luminal-like spheroids exhibited minimal changes. Our findings reveal heterogeneity in adrenergic receptor signaling across basal-like and luminal-like breast cancer cell lines, and also within the basal-like subgroup. This diversity underscores the complexity of adrenergic signaling in breast cancer and highlights the advantages of 3D culture systems. These results provide valuable insights into the subtype-specific patterns of response to adrenergic signaling that contribute to tumor progression and may inform future studies including evaluation of therapeutic strategies.
Keywords: breast cancer, adrenergic signaling, noradrenaline, Propranolol, Proteomics
Received: 08 Apr 2025; Accepted: 18 Aug 2025.
Copyright: © 2025 Carrasco, Bjørnstad, Vethe and Akslen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Manuel Carrasco, Centre for Cancer Biomarkers, Faculty of Medicine, University of Bergen, Bergen, 5020, Hordaland, Norway
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.